This is a summary of the European public assessment report (EPAR) for Zaltrap. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Zaltrap. For practical information about using Zaltrap, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Treatment of metastatic colorectal cancer (MCRC).
Therapeutic Area (MeSH)
ATC Code
L01XX44
ATC Item
aflibercept
Pharmacotherapeutic Group
Antineoplastic agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| aflibercept | N/A | 阿柏西普 |
EMA Name
Zaltrap
Medicine Name
Zaltrap
Aliases
N/ANo risk management plan link.
